BOSTON – CHI’s Bio-IT World magazine today announced that products from four bio-IT companies were named Best of Show Awards winners at a ceremony held here last night at the Sheraton Hotel Boston during the Life Sciences Conference + Expo: The winning products include MedScan from Ariadne Genomics Inc.; Discovery Solution 3.0 from Nervana Inc.; Clinical Trials Signal Detection System from Phase Forward Inc.; and Continuous Protection System 1200 from Revivio Inc.
Judged by a team of Bio-IT World magazine editors and highly regarded industry experts, Best of Show Awards recognize new products that demonstrate exceptional technology innovations across the life sciences research, discovery, and clinical trials process.
One company was selected in each of four technology categories. The following winners were selected from 14 finalists, based on the products’ technical merit, functionality and innovation, and in-person presentations to the judges at the show.
Clinical Trials & Research
Clinical Trials Signal Detection system from Phase Forward Inc.
Information Technology Infrastructure
Continuous Protection System 1200 from Revivio Inc.
Knowledge Management & Collaboration Tools
MedScan from Ariadne Genomics Inc.
Informatics Tools & Data
Discovery Solution 3.0 from Nervana Inc.
Product Details
CTSD, Phase Forward’s Clinical Trials Signal Detection system, combines tools for early detection and characterization of potential safety problems with a standards based repository for clinical trials data. While clinical trials data has in the past posed challenges to drug safety scientists due to issues such as small sample sizes and limited population diversity, recent market withdrawals of approved drugs due to safety issues have drawn the attention of pharmaceutical companies and regulators to the need for more careful evaluation of a drug’s safety profile prior to marketing approval. CTSD offers features to support internal signal detection, evaluation, and management during premarketing stages of drug development.
Revivio’s Continuous Protection System model CPS 1200 is a groundbreaking continuous data protection solution that allows companies to eliminate their backup windows, restore data instantly, exactly as it existed at any point or event in time, and recover business applications in just minutes. A fully fault-tolerant solution that supports the high availability required of mission-critical applications, the CPS 1200 seamlessly and nondisruptively fits into any enterprise storage environment. Revivio’s patent-pending technology allows administrators to instantly access all volumes used by an application – the entire dataset – as they existed at any previous point in time, a week, a day or even one second ago.
Ariadne’s advanced information extraction technology – MedScan - can initiate and facilitate the growth of biomedical semantic web content. MedScan extracts structured information from plain text by identifying individual biomedical named entities (proteins, cellular processes, small molecules, diseases, etc), and detecting relationships between them using domain-specific Natural Language Processing (NLP) algorithms. Wherever possible, named entities identified by MedScan are mapped to established nomenclature systems that can be linked to other information resources. MedScan is capable of converting virtually any biomedical text (documents, web pages, Pubmed abstracts) into categorized entity relationships, which are then stored as a semantic graph in RDF format. Thus, MedScan serves as a “Semantic Web adaptor” to any text-based source of biomedical information.
The Nervana Discovery Solution provides life science knowledge workers the ability to ask questions naturally, within the context of their meanings – in ways they never could before – crossing multiple domains and information repositories. Nervana’s unique technology provides sophisticated, dynamic semantic indexing and ranking of content on a wide array of data sources without the need for “manual tagging” or formal semantic markup. Nervana integrates with the major enterprise internal data sources such as Lotus Notes, Outlook, Microsoft SQL Server, Oracle 9i and above, and Documentum Content Management Server. Proprietary information can be connected to Nervana, as can public, web-based materials, making results more valuable.
Best of Show Award winners received honorary signage, an awards logo, and an engraved award. They also will be featured on the Bio-IT World website with additional coverage in an upcoming issue of the magazine.
About Bio-IT World, Inc.
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT professionals. Coverage focuses on the application of technology products and services to enable the life sciences R&D value chain in pharmaceutical, biotechnology, healthcare, government and academic research organizations, spanning basic research, drug discovery and development, clinical trials, and regulatory compliance.
The company’s premier publication, Bio-IT World and accompanying website, www.bio-itworld.com, deliver the latest news, analysis and information on the indispensable technologies driving innovation in the bio-IT community. Bio-IT World also produces the Life Sciences Conference + Expo, now in it’s fifth year, along with supporting multiple industry events as strategic and business partners. Bio-IT World has received more than 34 awards for editorial and design excellence.Established in September 2001, Bio-IT World, Inc., headquartered in Framingham, MA., is a business of Cambridge Healthtech Institute.
About Cambridge Healthtech Institute
CHI’s renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US. including The Molecular Medicine Tri-Conference, Beyond Genome, PepTalk, World Pharmaceutical Congress and the new acquired Bio-IT World’s Life Sciences Conference & Expo. The company strives to develop quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. Leading researchers and business experts from top pharmaceutical, biotech and academic organizations present their most current findings in a forum that features panel discussions and audience participation. Over the past 14 years, CHI has produced more than 400 conferences, attracting more than 50,000 attendees from around the world.
In addition to CHI’s vast conference portfolio, their media properties include PharmaWeek, available on the web only, Pharmaceutical Discovery which will relaunch in print and online in May following its acquisition last year from Advanstar Communications and Bio-IT World acquired in March 06.
# # #
For more information, contact:
Gina Bajenaru,
Director, Marketing Communications
Bio-IT World, Inc.
gina_bajenaru@bio-itworld.com
Press Contact:
Lisa Scimemi
Cambridge Healthtech Institute
Ph. (617) 630-1319
lscimemi@healthtech.com